论文部分内容阅读
为观察冠心病患者及冠心病合并糖尿病患者血清糖化低密度脂蛋白 (Gly LDL)指数的变化 ,对 68例 (合并糖尿病 2 8例 ,无糖尿病 40例 )冠心病患者和 2 9例对照者 ,采用氯化硝基四氮唑蓝还原比色法测定Gly LDL指数。结果 :冠心病组的Gly LDL指数较对照组明显增高 (P <0 .0 1 ) ;糖尿病冠心病组Gly LDL指数高于非糖尿病冠心病组(P <0 .0 5 )。结果提示 :冠心病患者Gly LDL增高 ,糖尿病合并冠心病者增高更明显 ;Gly LDL可能是促进糖尿病动脉粥样硬化发生和发展的一个因素 ,并可能作为糖尿病合并大血管并发症的间接指标之一。
In order to observe the changes of serum GLD-LDL index in patients with coronary heart disease and coronary heart disease complicated with diabetes, 68 patients with coronary heart disease (29 with diabetes mellitus and 40 without diabetes) and 29 controls were enrolled in this study. Determination of Gly LDL Index by Nitroblue tetrazolium Blue Reduction Colorimetry. Results: The Gly LDL index in coronary heart disease group was significantly higher than that in control group (P <0.01). GlyLDL index in coronary heart disease group was higher than that in non-diabetic coronary heart disease group (P <0.05). The results suggest that patients with coronary heart disease have elevated Gly LDL and increased diabetes with coronary heart disease. Gly LDL may be a factor to promote the development and progression of atherosclerosis in diabetes mellitus, and may be used as an indirect indicator of diabetic macrovascular complications .